Brainsight is an existing investee company wherein Redstart holds 4% on a fully converted & diluted basis.

Brainsight is engaged in the business of healthcare technology, where it uses AI enabled application to provide evidence-based treatment hooks for neurosurgeons, psychiatrists and neurologists; and a private and empathetic digital aid for patients, and related business activities.